STAT+: Pharmalittle: We’re reading about LillyDirect, India’s drug standards, and more
Lilly's plan to offer its Zepbound weight-loss drug directly may make it easier for pharmaceutical companies to target patients with their products.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because the familiar routine of online meetings and deadlines has returned. Moreover, today marks the lined up. So strap yourself in and grab a cup of stimulation. Our choice today is cinnamon hazelnut, for those tracking this sort of thing. Meanwhile. here is the latest menu of tidbits for you to peruse. Hope you have a smashing day, and do stay in touch. …
